Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 161 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 62578 |
| 552 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 15141 |
| 17114 | 1 | JIANGDA PATHOL//BETA CX//3 3 DIINDOLYLYMETHANE | 644 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | JIANGDA PATHOL | address | 135514 | 1% | 46% | 6 |
| 2 | BETA CX | authKW | 65249 | 0% | 67% | 2 |
| 3 | 3 3 DIINDOLYLYMETHANE | authKW | 48938 | 0% | 100% | 1 |
| 4 | 7 12 DIMETHYLBENZALPHAANTHRACENE DMBA | authKW | 48938 | 0% | 100% | 1 |
| 5 | AFFILIATED LIAOYANG CENT HOSP | address | 48938 | 0% | 100% | 1 |
| 6 | AGE AT DELIVERY | authKW | 48938 | 0% | 100% | 1 |
| 7 | ALL UNION ONCOL | address | 48938 | 0% | 100% | 1 |
| 8 | ANTICANCER DRUGS BIOTHER Y LIAONING PR | address | 48938 | 0% | 100% | 1 |
| 9 | BIOMARKERS AND MOLECULAR TARGETS | authKW | 48938 | 0% | 100% | 1 |
| 10 | BIOMED SCI CLIN MED SCI | address | 48938 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 6377 | 52% | 0% | 332 |
| 2 | Gastroenterology & Hepatology | 1112 | 13% | 0% | 83 |
| 3 | Public, Environmental & Occupational Health | 457 | 12% | 0% | 78 |
| 4 | Endocrinology & Metabolism | 109 | 6% | 0% | 40 |
| 5 | Surgery | 81 | 8% | 0% | 53 |
| 6 | Pathology | 70 | 4% | 0% | 23 |
| 7 | Obstetrics & Gynecology | 60 | 4% | 0% | 24 |
| 8 | Medicine, Research & Experimental | 15 | 3% | 0% | 20 |
| 9 | Medicine, General & Internal | 15 | 4% | 0% | 26 |
| 10 | Cell Biology | 13 | 5% | 0% | 29 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JIANGDA PATHOL | 135514 | 1% | 46% | 6 |
| 2 | AFFILIATED LIAOYANG CENT HOSP | 48938 | 0% | 100% | 1 |
| 3 | ALL UNION ONCOL | 48938 | 0% | 100% | 1 |
| 4 | ANTICANCER DRUGS BIOTHER Y LIAONING PR | 48938 | 0% | 100% | 1 |
| 5 | BIOMED SCI CLIN MED SCI | 48938 | 0% | 100% | 1 |
| 6 | BIOMED SEVILLA IBISCSICHUVR CARLOS 3 | 48938 | 0% | 100% | 1 |
| 7 | CANC PREVENT PUBL HLTH SCI | 48938 | 0% | 100% | 1 |
| 8 | CCPDD | 48938 | 0% | 100% | 1 |
| 9 | CHEMOTHER Y GASTROENTEROL UNIT | 48938 | 0% | 100% | 1 |
| 10 | COLORECTAL PREVENT MED | 48938 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER CAUSES & CONTROL | 7715 | 4% | 1% | 23 |
| 2 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 3361 | 3% | 0% | 21 |
| 3 | CANCER PREVENTION RESEARCH | 1377 | 1% | 0% | 6 |
| 4 | EUROPEAN JOURNAL OF CANCER PREVENTION | 1361 | 1% | 0% | 7 |
| 5 | BRITISH JOURNAL OF CANCER | 1272 | 3% | 0% | 22 |
| 6 | INTERNATIONAL JOURNAL OF CANCER | 1231 | 4% | 0% | 23 |
| 7 | CANCER DETECTION AND PREVENTION | 1102 | 1% | 0% | 6 |
| 8 | ANTICANCER RESEARCH | 976 | 3% | 0% | 20 |
| 9 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 972 | 2% | 0% | 10 |
| 10 | DISEASES OF THE COLON & RECTUM | 877 | 2% | 0% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |